Literature DB >> 10322500

Multiple chemotactic factors: fine control or redundancy?

M N Devalaraja1, A Richmond.   

Abstract

Recruitment of leukocytes either during development or to the site of injury is crucial. The molecular regulation of cell trafficking is complex but well orchestrated by the temporal and spatial expression of a multitude of chemokines (chemoattractant cytokines) and chemokine receptors. The chemokines, classified primarily into four classes (CC, C, CXC and CX3C) bind either to specific or shared receptors and often exhibit intra-class redundancy. At the cellular level, the biological activity of chemokines is finely controlled by varied receptor display, binding affinity and/or varied signal-transducing mechanisms. Perturbation in these finely regulated processes leads to acute or chronic inflammatory conditions, developmental abnormalities and tumorigenesis/angiogenesis.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10322500     DOI: 10.1016/s0165-6147(99)01342-5

Source DB:  PubMed          Journal:  Trends Pharmacol Sci        ISSN: 0165-6147            Impact factor:   14.819


  24 in total

Review 1.  Molecular machinations: chemokine signals in host-pathogen interactions.

Authors:  S W Chensue
Journal:  Clin Microbiol Rev       Date:  2001-10       Impact factor: 26.132

2.  Delayed wound healing in CXCR2 knockout mice.

Authors:  R M Devalaraja; L B Nanney; J Du; Q Qian; Y Yu; M N Devalaraja; A Richmond
Journal:  J Invest Dermatol       Date:  2000-08       Impact factor: 8.551

3.  Loss of transforming growth factor-beta signaling in mammary fibroblasts enhances CCL2 secretion to promote mammary tumor progression through macrophage-dependent and -independent mechanisms.

Authors:  Stacey L Hembruff; Iman Jokar; Li Yang; Nikki Cheng
Journal:  Neoplasia       Date:  2010-05       Impact factor: 5.715

4.  Developmental expression of two CXC chemokines, MIP-2 and KC, and their receptors.

Authors:  J Luan; Y Furuta; J Du; A Richmond
Journal:  Cytokine       Date:  2001-06-07       Impact factor: 3.861

Review 5.  Chemokines in Wound Healing and as Potential Therapeutic Targets for Reducing Cutaneous Scarring.

Authors:  Peter Adam Rees; Nicholas Stuart Greaves; Mohamed Baguneid; Ardeshir Bayat
Journal:  Adv Wound Care (New Rochelle)       Date:  2015-11-01       Impact factor: 4.730

Review 6.  The chemokine network. I. How the genomic organization of chemokines contains clues for deciphering their functional complexity.

Authors:  R Colobran; R Pujol-Borrell; M P Armengol; M Juan
Journal:  Clin Exp Immunol       Date:  2007-05       Impact factor: 4.330

Review 7.  Current status and challenges of cytokine pharmacology.

Authors:  Z Zídek; P Anzenbacher; E Kmonícková
Journal:  Br J Pharmacol       Date:  2009-04-03       Impact factor: 8.739

8.  RHAMM, a receptor for hyaluronan-mediated motility, compensates for CD44 in inflamed CD44-knockout mice: a different interpretation of redundancy.

Authors:  Shlomo Nedvetzki; Erez Gonen; Nathalie Assayag; Reuven Reich; Richard O Williams; Robin L Thurmond; Jing-Feng Huang; Birgit A Neudecker; Fu-Sheng Wang; Fu-Shang Wang; Eva A Turley; David Naor
Journal:  Proc Natl Acad Sci U S A       Date:  2004-12-13       Impact factor: 11.205

Review 9.  Chemokine receptor oligomerization and allostery.

Authors:  Bryan Stephens; Tracy M Handel
Journal:  Prog Mol Biol Transl Sci       Date:  2013       Impact factor: 3.622

Review 10.  Nf-kappa B, chemokine gene transcription and tumour growth.

Authors:  Ann Richmond
Journal:  Nat Rev Immunol       Date:  2002-09       Impact factor: 53.106

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.